# Comparison of the Pharmacodynamics and Pharmacokinetics of Insulin Aspart and Human Insulin in Elderly People With Type 2 Diabetes

> **NCT00676819** · PHASE4 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 19 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** insulin aspart
- **DRUG:** human insulin

## Key facts

- **NCT ID:** NCT00676819
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01-10
- **Primary completion:** 2002-07-19
- **Final completion:** 2002-07-19
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2017-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00676819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00676819, "Comparison of the Pharmacodynamics and Pharmacokinetics of Insulin Aspart and Human Insulin in Elderly People With Type 2 Diabetes". Retrieved via AI Analytics 2026-08-13 from https://api.ai-analytics.org/clinical/NCT00676819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*